Satyam, S.M.; Safaii, E.; Shameer, I.; Kumari, R.; Prabhakar, S.; Eltrabishi, M.T.Z.M.; El-Tanani, M.; Rehman, A.; Abdelfattah, M.T.M.W.M.
Metformin as a Metabolic Reprogramming Interface in Host–Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss. Antibiotics 2026, 15, 583.
https://doi.org/10.3390/antibiotics15060583
AMA Style
Satyam SM, Safaii E, Shameer I, Kumari R, Prabhakar S, Eltrabishi MTZM, El-Tanani M, Rehman A, Abdelfattah MTMWM.
Metformin as a Metabolic Reprogramming Interface in Host–Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss. Antibiotics. 2026; 15(6):583.
https://doi.org/10.3390/antibiotics15060583
Chicago/Turabian Style
Satyam, Shakta Mani, Ebrahim Safaii, Ilmia Shameer, Rashmi Kumari, Sainath Prabhakar, Mohamed Talat Zaky Mahmoud Eltrabishi, Mohamed El-Tanani, Abdul Rehman, and Mohamed Tarek Mohamed Wageh Mohamed Abdelfattah.
2026. "Metformin as a Metabolic Reprogramming Interface in Host–Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss" Antibiotics 15, no. 6: 583.
https://doi.org/10.3390/antibiotics15060583
APA Style
Satyam, S. M., Safaii, E., Shameer, I., Kumari, R., Prabhakar, S., Eltrabishi, M. T. Z. M., El-Tanani, M., Rehman, A., & Abdelfattah, M. T. M. W. M.
(2026). Metformin as a Metabolic Reprogramming Interface in Host–Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss. Antibiotics, 15(6), 583.
https://doi.org/10.3390/antibiotics15060583
